Literature DB >> 17003188

Accelerated fracture healing.

J Edward Puzas1, Jeff Houck, Susan V Bukata.   

Abstract

Acceleration of the fracture healing process would have far-reaching benefits for both civilians and military personnel. Decreasing the time to return to complete function would reduce medical costs, enhance quality of life by decreasing pain and increasing mobility, accelerate the return of professional athletes to their sport, and decrease the time for military recruits to enter active duty after injuries incurred in basic training. Moreover, augmenting the healing process may prevent the long-term disability caused by fracture nonunion. Currently available pharmaceutical agents may allow us to realize this goal. However, these agents need to be tested in prospective randomized clinical trials.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17003188     DOI: 10.5435/00124635-200600001-00033

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  9 in total

1.  Delayed short-course treatment with teriparatide (PTH(1-34)) improves femoral allograft healing by enhancing intramembranous bone formation at the graft-host junction.

Authors:  Masahiko Takahata; Edward M Schwarz; Tony Chen; Regis J O'Keefe; Hani A Awad
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

2.  Remote ischemic preconditioning enhances fracture healing.

Authors:  Mehmet Faruk Çatma; Hakan Şeşen; Aytekin Aydın; Serhan Ünlü; İsmail Demirkale; Murat Altay
Journal:  J Orthop       Date:  2015-06-13

3.  Teriparatide therapy and beta-tricalcium phosphate enhance scaffold reconstruction of mouse femoral defects.

Authors:  Justin A Jacobson; Laura Yanoso-Scholl; David G Reynolds; Tulin Dadali; Gino Bradica; Susan Bukata; Edward J Puzas; Michael J Zuscik; Randy Rosier; Regis J O'Keefe; Edward M Schwarz; Hani A Awad
Journal:  Tissue Eng Part A       Date:  2010-10-29       Impact factor: 3.845

4.  Teriparatide therapy enhances devitalized femoral allograft osseointegration and biomechanics in a murine model.

Authors:  David G Reynolds; Masahiko Takahata; Amy L Lerner; Regis J O'Keefe; Edward M Schwarz; Hani A Awad
Journal:  Bone       Date:  2010-10-13       Impact factor: 4.398

5.  Effect of VEGF-A165 addition on the integration of a cortical allograft in a tibial segmental defect in rabbits.

Authors:  Miguel Angel Ruiz-Ibán; Fausto Gonzalez-Lizán; Jorge Diaz-Heredia; Maria Elena Elías-Martin; Carlos Correa Gorospe
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-12-03       Impact factor: 4.342

6.  Teriparatide, a nonsurgical solution for femoral nonunion? A report of three cases.

Authors:  Y-K Lee; Y-C Ha; K-H Koo
Journal:  Osteoporos Int       Date:  2012-10-18       Impact factor: 4.507

Review 7.  The role of PGRN in musculoskeletal development and disease.

Authors:  Jessica Konopka; Brendon Richbourgh; Chuanju Liu
Journal:  Front Biosci (Landmark Ed)       Date:  2014-01-01

8.  Teriparatide Therapy as an Adjuvant for Tissue Engineering and Integration of Biomaterials.

Authors:  Robinder S Dhillon; Edward M Schwarz
Journal:  J Mater Res       Date:  2011-06-01       Impact factor: 3.089

9.  Successful treatment of nonunion with teriparatide after failed ankle arthrodesis for Charcot arthropathy.

Authors:  K Tamai; K Takamatsu; K Kazuki
Journal:  Osteoporos Int       Date:  2013-05-07       Impact factor: 4.507

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.